The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout ...

From breaking news to special features, we're on it! Join the NonStop Local Chord group and always be in the know. MONDAY, April 21, 2025 (HealthDay News) -- The U.S. Food and Drug Administration ...

MONDAY, April 21, 2025 (HealthDay News) -- The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout for counterfeit Ozempic ...

Pharmacies and patients are urged to double-check their Ozempic box to see if it features the combination of lot number and incorrect serial number. If so, these products are considered ...

MONDAY, April 21, 2025 (HealthDay News) -- The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout for counterfeit Ozempic ...

Lee Rosebush, chairman of lead plaintiff Outsourcing Facilities Association, told Reuters that his organization had presented evidence of an ongoing semaglutide shortage that was obtained after ...

(Reuters) -A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular ...

That came in response to a February lawsuit from a compounding trade group against the Food and Drug Administration's determination that the active ingredient in those drugs, semaglutide ...

Compounding pharmacies have been allowed to make generic semaglutide — the active ingredient in the blockbuster drugs — due to a short supply of the brand name medications that started in 2022.